Skip to content

Analysis of the effect of exercise-assisted therapy on improving mood disorders

Analysis of the effect of exercise-assisted therapy on improving mood disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040228
Enrollment
Unknown
Registered
2020-11-25
Start date
2020-11-26
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Group A:Sports +Venlafaxine Hydrochloride + Oxazepam
Group B:Venlafaxine Hydrochloride + Oxazepam

Sponsors

Tongji Medical College Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-50 years old; 2. Depressed patients who meet the criteria of "Diagnostic and Statistical Manual of Mental Disorders" Fifth Edition (DSM-V) and have no eye diseases; 3. Mild to moderate depression, 21-item Hamilton Depression Scale score 7-24 points; 4. Have not previously received psychotropic drugs or psychotherapy; 5. No aerobic exercise habits (such as brisk walking, jogging, swimming, dancing, biking, etc.), and the total weekly aerobic exercise time is less than 60 minutes; 6. Native Chinese; 7. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Suffer from diseases that significantly affect the function of the autonomic nervous system (hyperthyroidism or hypothyroidism, diabetes, obstructive sleep apnea syndrome, etc.); 2) Past history of syncope, family history of sudden cardiac death; 3) Suffering from organic diseases that are not suitable for exercise, such as exercise-related asthma, arthritis, gout, cancer, Crohn's disease, fractures, and heart diseases (including coronary heart disease, hypertrophic cardiomyopathy, arrhythmia and heart failure, etc.); 4) Suffered from other mental illnesses (such as schizophrenia, bipolar disorder, anxiety disorder, suicidal tendency or depression with psychotic symptoms, alcohol and illegal drug abuse, etc.) in the past or at the first visit; 5) Taking drugs that significantly affect the function of the autonomic nervous system (such as beta blockers); 6) There are clear contraindications to SSRIs or benzodiazepines; 7) Cannot continue moderate-intensity exercise for more than 40 minutes; 8) Correcting vision or hearing affects sports safety; 9) Are participating in clinical research projects related to sports or weight management; 10) Female patients who are pregnant, breastfeeding, or have a pregnancy plan in the next 3 months.

Design outcomes

Primary

MeasureTime frame
Remission rate of depression;Autonomic dysfunction improvement rate;

Countries

China

Contacts

Public ContactYuan Yang

Tongji Medical College Huazhong University of Science and Technolog

1453026875@qq.com+86 13995561816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026